XML 16 R6.htm IDEA: XBRL DOCUMENT v3.22.2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Treasury Stock
Accumulated Other Comprehensive Income
Accumulated Earnings (Deficit)
Beginning balance (in shares) at Dec. 31, 2020   93,379,508        
Beginning balance at Dec. 31, 2020 $ 127,871 $ 9 $ 179,549   $ 93 $ (51,780)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Repurchase of common stock (in shares)       (2,326,413)    
Repurchase of common stock       $ (25,498)    
Stock-based compensation 1,593   1,593      
Unrealized gain on investment in convertible notes 469       469  
Net income 1,501         1,501
Ending balance (in shares) at Mar. 31, 2021   93,379,508        
Ending balance at Mar. 31, 2021 131,434 $ 9 181,142   562 (50,279)
Beginning balance (in shares) at Dec. 31, 2020   93,379,508        
Beginning balance at Dec. 31, 2020 127,871 $ 9 179,549   93 (51,780)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Unrealized gain on interest rate caplets 0          
Unrealized gain on investment in convertible notes 5,673          
Net income 13,946          
Ending balance (in shares) at Jun. 30, 2021   93,660,753        
Ending balance at Jun. 30, 2021 151,916 $ 9 183,975   5,766 (37,834)
Beginning balance (in shares) at Mar. 31, 2021   93,379,508        
Beginning balance at Mar. 31, 2021 131,434 $ 9 181,142   562 (50,279)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock-based compensation 2,148   2,148      
Exercise of common stock options (in shares)   281,245        
Exercise of common stock options 685   685      
Unrealized gain on interest rate caplets 0          
Unrealized gain on investment in convertible notes 5,204       5,204  
Net income 12,445         12,445
Ending balance (in shares) at Jun. 30, 2021   93,660,753        
Ending balance at Jun. 30, 2021 151,916 $ 9 183,975   5,766 (37,834)
Beginning balance (in shares) at Dec. 31, 2021   93,410,563        
Beginning balance at Dec. 31, 2021 158,461 $ 9 187,656 $ (8,983) 0 (20,221)
Beginning balance (in shares) at Dec. 31, 2021       (701,305)    
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Repurchase of common stock (in shares)   (1,087,990)   (1,087,990)    
Repurchase of common stock (13,934)     $ (13,934)    
Stock-based compensation 1,605   1,605      
Exercise of stock-based awards (in shares)   161,969        
Exercise of stock-based awards 38   38      
Unrealized gain on interest rate caplets 4,864       4,864  
Net income 15,788         15,788
Ending balance (in shares) at Mar. 31, 2022   92,484,542        
Ending balance at Mar. 31, 2022 166,822 $ 9 189,299 $ (22,917) 4,864 (4,433)
Ending balance (in shares) at Mar. 31, 2022       (1,789,295)    
Beginning balance (in shares) at Dec. 31, 2021   93,410,563        
Beginning balance at Dec. 31, 2021 $ 158,461 $ 9 187,656 $ (8,983) 0 (20,221)
Beginning balance (in shares) at Dec. 31, 2021       (701,305)    
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Repurchase of common stock (in shares) (3,414,403)          
Repurchase of common stock $ (39,400)          
Unrealized gain on interest rate caplets 6,771          
Unrealized gain on investment in convertible notes 0          
Net income 38,252          
Ending balance (in shares) at Jun. 30, 2022   90,759,331        
Ending balance at Jun. 30, 2022 173,875 $ 9 191,190 $ (42,126) 6,771 18,031
Ending balance (in shares) at Jun. 30, 2022       (3,600,086)    
Beginning balance (in shares) at Mar. 31, 2022   92,484,542        
Beginning balance at Mar. 31, 2022 166,822 $ 9 189,299 $ (22,917) 4,864 (4,433)
Beginning balance (in shares) at Mar. 31, 2022       (1,789,295)    
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Repurchase of common stock (in shares)   (2,326,413)        
Repurchase of common stock (25,498)          
Reissuance of treasury stock in business combination (in shares)   515,622   515,622    
Reissuance of treasury stock in business combination 5,584   (705) $ 6,289    
Stock-based compensation 2,281   2,281      
Exercise of stock-based awards (in shares)   85,580        
Exercise of stock-based awards 315   315      
Unrealized gain on interest rate caplets 1,907       1,907  
Unrealized gain on investment in convertible notes 0          
Net income 22,464         22,464
Ending balance (in shares) at Jun. 30, 2022   90,759,331        
Ending balance at Jun. 30, 2022 $ 173,875 $ 9 $ 191,190 $ (42,126) $ 6,771 $ 18,031
Ending balance (in shares) at Jun. 30, 2022       (3,600,086)